Genocea’s mission is to help conquer cancer through targeted vaccines and immunotherapies. Two things make us unique: our team and our technology. Learn more about our team here. Learn more about our ATLAS™ platform, and the ways it may enable us to make differentiated cancer immunotherapies here. Our lead program, GEN-009, uses the ATLAS platform to optimize neoantigen selection for personalized cancer vaccines. We are cu...
Genocea’s mission is to help conquer cancer through targeted vaccines and immunotherapies. Two things make us unique: our team and our technology. Learn more about our team here. Learn more about our ATLAS™ platform, and the ways it may enable us to make differentiated cancer immunotherapies here. Our lead program, GEN-009, uses the ATLAS platform to optimize neoantigen selection for personalized cancer vaccines. We are currently evaluating the safety, immunogenicity & efficacy of GEN-009 in a Phase 1/2a clinical trial. We are a publicly traded company listed on NASDAQ under the ticker symbol GNCA. Genocea is headquartered in Cambridge.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.